Please find attached the first half 2024 financial report including the Responsibility Statement. ***** For further information, please contact: Alexander KarlsenCFO+47 97 05 36 21Alexander.karlsen@vistin.com This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act
Attachment
Vistin Pharma ASA Q2 report 2024